and Looper, K.J., 2009
In February 2026, full results from the REDEFINE 2 study showed CagriSema achieving 23% weight loss at 84 weeks but falling short of its primary endpoint under the treatment policy estimand (which measures efficacy across all patients regardless of whether they completed treatment, rather than only those who remained on it)
Skipping doses, doubling doses, changing syringe units, copying another patients instructions, or using online dose charts can create confusion and risk
Your clinician will determine which therapy, if any, is appropriate based on your BMI, medical history and treatment goals
Should We Be Concerned About Glucagon-Like Peptide-1 Receptor Agonists
Vulva changes after weight loss can include loose or sagging skin and loss of fat volume in the mons pubis the fatty mound above the pubic bone and the labia majora, which are the outer lips of the vulva